Cervical lesion drug trial halted early
Disease control
Terminated
This study tested a vaginal insert called ABI-2280 in women with cervical precancerous lesions (CIN). The goal was to see if it was safe and could help clear the abnormal cells. The trial was stopped early, so we don't have full results. It involved 44 women aged 25-55 who used t…
Phase: PHASE1, PHASE2 • Sponsor: Antiva Biosciences • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC